Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists01:28

Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists

518
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy.  SP binds and activates...
518
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists01:27

Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists

567
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
567
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

18.4K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
18.4K
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists01:29

Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists

787
Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
787

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Electrolyte-Framework Matching in High-Voltage TEMPO-COF Cathodes for Lithium Batteries.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
Same author

Structure-Based Discovery of Potent BCL-XL Inhibitors through Rescaffolding.

Journal of medicinal chemistry·2026
Same author

Optical coherence photoacoustic microscopy for 3D cancer model imaging with AI-assisted organoid analysis.

Light, science & applications·2026
Same author

Endothelial defects unveil cardiovascular phenotype in iPSC-based disease modelling across three generations of a DiGeorge syndrome family.

Research square·2025
Same author

Human ectodermal organoids reveal the cellular origin of DiGeorge Syndrome.

bioRxiv : the preprint server for biology·2025
Same author

Organometallic Half-Sandwich Complexes of 1,10-Phenanthroline Derivatives with Improved Solubility, Albumin-Binding, and Nanoformulation Potential Targeting Drug Resistance in Cancer.

Inorganic chemistry·2025

Related Experiment Video

Updated: Jan 9, 2026

Amide Coupling Reaction for the Synthesis of Bispyridine-based Ligands and Their Complexation to Platinum as Dinuclear Anticancer Agents
07:20

Amide Coupling Reaction for the Synthesis of Bispyridine-based Ligands and Their Complexation to Platinum as Dinuclear Anticancer Agents

Published on: May 28, 2014

14.4K

Imidazolinium-Based NHC-Metal Complexes Overcome Both Cancer Multidrug Resistance and Cisplatin Resistance In Vitro.

Márton Szlávik1,2, Lidia Ines Haffarases3,4, Réka Mandel3

  • 1Servier Research Institute of Medicinal Chemistry, Záhony Utca 7, H-1031 Budapest, Hungary.

International Journal of Molecular Sciences
|December 11, 2025
PubMed
Summary

New N-heterocyclic carbene (NHC) metal complexes show potent anticancer activity. Imidazolinium-based compounds, particularly those with copper and silver, demonstrate significant cytotoxicity and overcome drug resistance, offering promising cancer treatment potential.

Keywords:
ABCB1N-heterocyclic carbenecisplatin resistancemultidrug resistance

More Related Videos

Anticancer Metal Complexes: Synthesis and Cytotoxicity Evaluation by the MTT Assay
11:14

Anticancer Metal Complexes: Synthesis and Cytotoxicity Evaluation by the MTT Assay

Published on: November 10, 2013

58.7K
Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer
09:40

Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer

Published on: August 2, 2024

3.1K

Related Experiment Videos

Last Updated: Jan 9, 2026

Amide Coupling Reaction for the Synthesis of Bispyridine-based Ligands and Their Complexation to Platinum as Dinuclear Anticancer Agents
07:20

Amide Coupling Reaction for the Synthesis of Bispyridine-based Ligands and Their Complexation to Platinum as Dinuclear Anticancer Agents

Published on: May 28, 2014

14.4K
Anticancer Metal Complexes: Synthesis and Cytotoxicity Evaluation by the MTT Assay
11:14

Anticancer Metal Complexes: Synthesis and Cytotoxicity Evaluation by the MTT Assay

Published on: November 10, 2013

58.7K
Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer
09:40

Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer

Published on: August 2, 2024

3.1K

Area of Science:

  • Inorganic Chemistry
  • Medicinal Chemistry
  • Materials Science

Background:

  • N-heterocyclic carbenes (NHCs) are versatile ligands in coordination chemistry.
  • Metal complexes incorporating NHCs have shown potential in various biological applications, including anticancer therapy.
  • Developing novel metal-NHC complexes with enhanced efficacy and reduced resistance is crucial for advancing cancer treatment.

Purpose of the Study:

  • To synthesize and characterize novel gold(I), silver(I), copper(I), and palladium(II) NHC complexes.
  • To evaluate the in vitro cytotoxicity of these complexes against cancer cell lines, including multidrug-resistant variants.
  • To investigate the mechanisms of action, such as apoptosis induction and reactive oxygen species (ROS) production.

Main Methods:

  • Synthesis of imidazolinium- and imidazolium-based NHC ligands and their corresponding metal complexes.
  • Cytotoxicity assays using Mes-Sa uterine sarcoma and CST murine breast cancer cell lines.
  • Assessment of resistance mechanisms, including ABCB1-overexpression and cisplatin resistance.
  • Apoptosis assays and intracellular ROS level measurements.

Main Results:

  • Imidazolinium-based NHC complexes exhibited superior cytotoxicity compared to imidazolium counterparts.
  • Biscarbene complexes showed significantly enhanced cytotoxicity with nanomolar activity.
  • Monocarbene imidazolinium complexes demonstrated marginal resistance in ABCB1-overexpressing cells, suggesting evasion of multidrug resistance.
  • Copper and silver complexes displayed potent cytotoxicity against both sensitive and resistant cancer cell lines, with copper complexes inducing ROS production.

Conclusions:

  • Imidazolinium-based metal NHCs are promising anticancer drug candidates.
  • Copper and silver NHC complexes exhibit potent cytotoxicity and can overcome ABCB1-mediated and cisplatin resistance.
  • These findings highlight the therapeutic potential of NHC metal complexes in oncology.